Pesquisar
Abbott Laboratories
ABTAdicionar à lista de desejos
108.330USD
-0.460-0.42%
Fechamento 09-04 16:00（ET）
187.42BValor de mercado
30.05P/L TTM
Mais detalhes de Abbott Laboratories Empresa
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.
Abbott Laboratories Perfil
Código da empresaABT
Nome da EmpresaAbbott Laboratories
Data de listagemApr 06, 2073
CEOFord (Robert B)
Número de funcionários114000
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 06
Endereço100 Abbott Park Road
CidadeABBOTT PARK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60064-3500
Telefone12246676100
Sitehttps://www.abbott.com
Código da empresaABT
Data de listagemApr 06, 2073
CEOFord (Robert B)
Executivos da empresa Abbott Laboratories
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Perguntas frequentes
Quem são os cinco principais acionistas de Abbott Laboratories?
Os cinco principais acionistas de Abbott Laboratories são: Mr. Daniel J. Starks
Quantas instituições possuem ações da Abbott Laboratories (ABT)?
Em 2026Q1, 4859 instituições possuíam ações da Abbott Laboratories, com valor de mercado aproximado de 1.25B, representando 71.75% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -187252308.00.
Qual é a maior fonte de receita da Abbott Laboratories?
Em 2026Q1, o segmento de negócios Diabetes Care gerou a maior receita para Abbott Laboratories, totalizando 2.19B e representando 17.37% da receita total.